SEC Form 4 · accession 0001513162-15-000363
Anixa Biosciences Inc · ANIX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
Amit Kumar
Director
Period of report
Jun 19, 2015
Accepted (ET)
Jun 23, 2015 · 5:05 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000715446
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 19, 2015 | P | 50,000 | $0.1435 | A | 2,052,691 | D | |
| Common Stock | Jun 22, 2015 | P | 50,000 | $0.151 | A | 21,002,691 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.14 to $0.1444, inclusive. The reporting person undertakes to provide to ITUS Corporation, any security holder of ITUS Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth.